Publication: 4763

Publication: 4763

Alliance A022104/NRG-GI010, a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer (LARC): The Janus Rectal Cancer trial.

DOI

Google Scholar

Citation:

Meeting Instance:: ASCO GI 2026
Year:: 2026
Type:: Abstract
Sub type:
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub-ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180820 (ECOG-ACRIN); U10CA180868 (NRG Oncology); U10CA180888 (SWOG)

Corr. Author:
Authors:: Caleah S. Kitchens Qian Shi Arvind Dasari Julio Garcia‑Aguilar Hanna Sanoff Thomas J. George Theodore Hong Greg Yothers Philip Philip Tareq Al Baghdadi Olatunji B. Alese Emmanouil P. Pappou Andrea Cercek Eileen M. O'Reilly Jeffrey A. Meyerhardt Ardaman Shergill Natally Horvat Paul B. Romesser William Hall J. Joshua Smith

Networks:: LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NY016, MCRC, PCRC

Study: Alliance-A022104
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: